Clearbridge Investments, LLC Lannett CO Inc Transaction History

Clearbridge Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$6.43 - $9.86 $23,405 - $35,890	-3,640 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$6.36 - $10.05 $699 - $1,105	-110 Reduced 2.93%	3,640 $25,000
Q4 2019 Feb 14, 2020	BUY	$8.49 - $12.81 $31,837 - $48,037	3,750 New	3,750 $33,000
Q4 2018 Feb 14, 2019	SELL	$3.43 - $6.19 $4,802 - $8,666	-1,400 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$4.75 - $14.5 $23 - $72	-5 Reduced 0.36%	1,400 $7,000
Q2 2018 Aug 14, 2018	SELL	$13.3 - $17.45 $93 - $122	-7 Reduced 0.5%	1,405 $19,000
Q4 2017 Feb 14, 2018	BUY	$19.9 - $29.25 $28,098 - $41,301	1,412	1,412 $33,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.